Indian Immunologicals Ltd. (IIL), a subsidiary of the National Dairy Development Board (NDDB), has launched Raksha-IBR, India’s first indigenously developed glycoprotein E (gE) deleted DIVA marker vaccine against Infectious Bovine Rhinotracheitis (IBR).
About Raksha-IBR Vaccine
- Type: gE deleted DIVA (Differentiation of Infected from Vaccinated Animals) marker vaccine.
- Function: Helps differentiate infected from vaccinated animals (DIVA approach).
About Glycoprotein E (gE)
- It is a structural protein found on the surface of Bovine Herpes Virus-1 (BHV-1).
- It plays a key role in virus virulence, cell-to-cell spread, and evasion of the host’s immune response.
|
- Working Mechanism:
- The deletion of the gE gene allows for a Differentiation of Infected from Vaccinated Animals i.e DIVAApproach.
- Vaccinated animals will not produce antibodies against gE, while animals naturally infected with the wild-type virus will.
- Diagnostic tests can then differentiate between vaccinated and naturally infected animals, which is crucial for disease eradication programs.
Comparative table between DIVA marker vaccines and Traditional vaccines
Aspect |
DIVA Marker Vaccine |
Traditional Vaccine |
Composition |
Lacking specific immunogenic markers (e.g., gE protein) |
Contains whole pathogen or major antigens |
Serological Differentiation |
Enables distinguishing infected from vaccinated animals via specific tests |
Does not allow differentiation, same antibody response in both |
Disease Surveillance |
Supports better disease monitoring and eradication programs |
Complicates disease surveillance and monitoring |
Diagnostic Tests Required |
Companion diagnostic tests (e.g., ELISA for marker antibodies) needed |
No specific companion tests |
Vaccine Types |
Often deletion mutants, subunit, or vectored vaccines |
Live attenuated or inactivated whole pathogen vaccines |
Safety |
Generally safer due to deletion of virulence factors |
Depends on vaccine type; live vaccines carry slight risk |
Use in Eradication Programs |
Highly suitable due to DIVA approach |
Less suitable due to inability to differentiate infection |
Significance for Dairy Sector
- Largest Milk Producer: India leads globally in milk production; protecting cattle health is vital for sustaining growth.
- Productivity Gains: Preventing IBR will improve fertility rates, milk yield, and economic returns for farmers.
- Biosecurity Support: Enables systematic vaccination campaigns, aiding in better disease management and herd health.
- Self-Reliance: Reduces dependence on imported vaccines, strengthening India’s Atmanirbhar Bharat initiative in animal health.
What is Infectious Bovine Rhinotracheitis (IBR) ?
- Infectious Bovine Rhinotracheitis (IBR) is a highly contagious viral disease of cattle caused by Bovine Herpes Virus-1 (BHV-1)
- It primarily affects the respiratory tract, causing fever, nasal discharge, coughing, and conjunctivitis.
- Transmission: Transmission occurs through aerosols, direct contact, and infected semen.
- Symptoms: Respiratory form (fever, conjunctivitis, rhinitis, tracheitis, pneumonia in feedlots) and Venereal form (pustular lesions in bull prepuce/penis and cow vulva/vagina, affecting reproduction). Some strains also cause abortion.
- Impacts: It also leads to reproductive disorders such as infertility, abortions, and reduced milk production.
- Treatment: No specific treatment; prevention through vaccination and biosecurity is crucial.
- Diagnosis: Serology, virus isolation, and semen certification by real-time PCR for viral DNA.
About Bovine Herpes Virus-1 (BHV-1)
- Bovine herpesvirus-1 (BoHV-1) causes two major cattle diseases – Infectious Bovine Rhinotracheitis (IBR) and Infectious Pustular Vulvovaginitis (IPV) – both are endemic in India.
|